pubmed-article:16802866 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16802866 | lifeskim:mentions | umls-concept:C0013835 | lld:lifeskim |
pubmed-article:16802866 | lifeskim:mentions | umls-concept:C0007589 | lld:lifeskim |
pubmed-article:16802866 | lifeskim:mentions | umls-concept:C0003261 | lld:lifeskim |
pubmed-article:16802866 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:16802866 | lifeskim:mentions | umls-concept:C0205100 | lld:lifeskim |
pubmed-article:16802866 | lifeskim:mentions | umls-concept:C0920725 | lld:lifeskim |
pubmed-article:16802866 | lifeskim:mentions | umls-concept:C1511938 | lld:lifeskim |
pubmed-article:16802866 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:16802866 | pubmed:dateCreated | 2006-6-28 | lld:pubmed |
pubmed-article:16802866 | pubmed:abstractText | We examined the effects of in vivo exposure to a GSM-modulated 900 MHz RF field on B-cell peripheral differentiation and antibody production in mice. Our results show that exposure to a whole-body average specific absorption rate (SAR) of 2 W/kg, 2 h/day for 4 consecutive weeks does not affect the frequencies of differentiating transitional 1 (T1) and T2 B cells or those of mature follicular B and marginal zone B cells in the spleen. IgM and IgG serum levels are also not significantly different among exposed, sham-exposed and control mice. B cells from these mice, challenged in vitro with LPS, produce comparable amounts of IgM and IgG. Moreover, exposure of immunized mice to RF fields does not change the antigen-specific antibody serum level. Interestingly, not only the production of antigen-specific IgM but also that of IgG (which requires T-B-cell interaction) is not affected by RF-field exposure. This indicates that the exposure does not alter an ongoing in vivo antigen-specific immune response. In conclusion, our results do not indicate any effects of GSM-modulated RF radiation on the B-cell peripheral compartment and antibody production and thus provide no support for health-threatening effects. | lld:pubmed |
pubmed-article:16802866 | pubmed:language | eng | lld:pubmed |
pubmed-article:16802866 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16802866 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16802866 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16802866 | pubmed:month | Jun | lld:pubmed |
pubmed-article:16802866 | pubmed:issn | 0033-7587 | lld:pubmed |
pubmed-article:16802866 | pubmed:author | pubmed-author:PioliClaudioC | lld:pubmed |
pubmed-article:16802866 | pubmed:author | pubmed-author:PintoRosannaR | lld:pubmed |
pubmed-article:16802866 | pubmed:author | pubmed-author:LovisoloGiorg... | lld:pubmed |
pubmed-article:16802866 | pubmed:author | pubmed-author:MarinoCarmela... | lld:pubmed |
pubmed-article:16802866 | pubmed:author | pubmed-author:NastaFrancesc... | lld:pubmed |
pubmed-article:16802866 | pubmed:author | pubmed-author:PriscoMaria... | lld:pubmed |
pubmed-article:16802866 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16802866 | pubmed:volume | 165 | lld:pubmed |
pubmed-article:16802866 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16802866 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16802866 | pubmed:pagination | 664-70 | lld:pubmed |
pubmed-article:16802866 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:meshHeading | pubmed-meshheading:16802866... | lld:pubmed |
pubmed-article:16802866 | pubmed:year | 2006 | lld:pubmed |
pubmed-article:16802866 | pubmed:articleTitle | Effects of GSM-modulated radiofrequency electromagnetic fields on B-cell peripheral differentiation and antibody production. | lld:pubmed |
pubmed-article:16802866 | pubmed:affiliation | ENEA (Italian Agency for New Technologies, Environment and Energy), Section of Toxicology and Biomedicine, Rome, Italy. | lld:pubmed |
pubmed-article:16802866 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16802866 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |